BWS
WST icon

Buck Wealth Strategies’s West Pharmaceutical WST Stock Holding History

Buck Wealth Strategies’s Portfolio WST Stock Details WST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$359 Buy
+1
New +$306 ﹤0.01% 1040

Other funds holding WST

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
GIM
Generation Investment Management London, United Kingdom $10.3B AUM 4.84% 1-Year Est. Return
TD Asset Management
TD Asset Management Toronto, Ontario, Canada $115B AUM 41.58% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return
Russell Investments Group
Russell Investments Group London, United Kingdom $114B AUM 41.71% 1-Year Est. Return
Envestnet Asset Management
Envestnet Asset Management Chicago, Illinois $424B AUM 22.96% 1-Year Est. Return
RP
Riverbridge Partners Minneapolis, Minnesota $3.58B AUM 4.02% 1-Year Est. Return
BTCPP
Border to Coast Pensions Partnership Leeds, United Kingdom $6.78B AUM 31.6% 1-Year Est. Return

Buck Wealth Strategies's WST Position: Q2 2026 in Review

Buck Wealth Strategies opened a new position in West Pharmaceutical (WST) in Q2 2026: 1 share worth $359. The stake represents ﹤0.01% of the portfolio and ranks #1040 among its holdings.

461 funds tracked by Wall St. Rank hold WST as of Q2 2026.

  • Buck Wealth Strategies held 1 share of West Pharmaceutical worth $359 as of Q2 2026.
  • West Pharmaceutical was a new Buck Wealth Strategies position in Q2 2026.
  • West Pharmaceutical made up ﹤0.01% of Buck Wealth Strategies's portfolio in Q2 2026, its #1040 holding.
  • 461 funds tracked by Wall St. Rank held West Pharmaceutical as of Q2 2026.

Based on Buck Wealth Strategies's 13F filing for Q2 2026, filed 30 Jul 2026.